Understanding the mechanisms underlying OPA1-mediated disruption in mitochondrial dynamics offers great potential to clarify the pathogenesis of ADOA and find potential therapeutic strategies [56]. The gene discussed is OPA1; the disease is autosomal dominant optic atrophy.